Choose from Viking Logos Clip Art stock illustrations from iStock. Find high-quality royalty-free vector images that you won't find anywhere else. Video Back Videos home Signature collection ...
Scotiabank initiated coverage of Viking Therapeutics (VKTX) with an Outperform rating and $102 price target Maximize Your Portfolio with Data ...
H.C. Wainwright analyst Joseph Pantginis reiterated a Buy rating on Viking Therapeutics (VKTX – Research Report) today and set a price target ...
The Minnesota Vikings drafted quarterback J.J. McCarthy out of Michigan at No. 10 overall in the 2024 NFL Draft and his chance at playing his rookie year was gone quickly because of a knee injury ...
Minnesota Vikings coach Kevin O'Connell said recently that quarterback Sam Darnold has "earned the right to be a free agent" this offseason, all but guaranteeing the veteran will test the market.
Two healthcare stocks in the white-hot weight-loss segment tanked ... NVO), famously the company behind Wegovy, and Viking Therapeutics (NASDAQ: VKTX), which is far along in its development ...
Viking Therapeutics traded as low as $31.00 and last traded at $30.97. 886,719 shares traded hands during trading, a decline of 77% from the average session volume of 3,895,525 shares. The stock ...
VKTX opened at $32.56 on Thursday. The company has a market cap of $3.63 billion, a PE ratio of -35.01 and a beta of 0.90. Viking Therapeutics has a twelve month low of $25.34 and a twelve month ...
In this article, we are going to take a look at where Viking Therapeutics, Inc. (NASDAQ:VKTX) stands against other stocks that Jim Cramer has shared his thoughts on. Jim Cramer, the host of Mad ...
Shares of Viking Therapeutics have fallen by more than half since the stock peaked early last year. Viking Therapeutics is developing a drug that might be able to outperform today's most popular ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results